Invest ontario providing a CAD grant in the amount of 16.1 million dollars. USA to support the growth of the sector of life.
British pharmaceutical giant Astrazeneca It invests in Canada $ 820 million in Canada to support its move to a larger office in the Bolshoi Toronto area.
Astrazeneca said that investments will create more than high 700 jobs in all areas of their business and contribute to its achievement of 20 new drugs for patients around the world by 2030, eight of which have already been launched.
Prime Minister Dug Ford announced that the Ontario government was making a CAD grant in the amount of 16.1 million dollars. The United States through Investa Ontario to support the company's efforts to expand, adding that the new jobs will strengthen the Ontario position as a world leader in the field of life and innovation sciences.
“This investment is a reflection […] Our strong faith in Canada’s potential as a global center for life sciences. ”
Pascal Soriot
Astrazeneca
Extended operations will strengthen the research and capabilities of Astrazeneca and improve the design of clinical tests in the field of oncology, immunology and infectious diseases, using Ontario in the statement.
Invest ontario added that he also provided Astrazeneca with the service of choosing a site, market intelligence and immigration support to simplify the investment process.
“These investments are a reflection of our growing clinical conveyor, our strong faith in Canada’s potential as a global center of science of life sciences, as well as the value of public-private cooperation with the Ontario government,” said Astrazeneca Pascal Soriot, General Director.
Ontario seeks to establish itself as a global center for biopriet and life sciences, as evidenced launch The second stage of his strategy for life in October last year. The phase, which includes $ 146 million. The United States in the field of provincial expenses has established the goal of developing biopries and sciences of biological production of the province and at 85,000 high -value jobs by 2030.
CONNECTED: Fusion Pharmaceuticals, which will be purchased by Astrazeneca for more than $ 2 billion
Astrazeneca said she created more than 1,200 jobs and invested more than 1.3 billion dollars. USA in Canada since 2023. The pharmaceutical company also acquired A biopharmaceutical oncological company based on Hamilton Fusion Pharmaceuticals for CAD for $ 3 billion in June last year.
“We believe that a variety of talents, together with a network of world-class universities, hospitals and research centers, will help us bring new medicines to Canadians and patients around the world,” said Soriot.
The image is provided by Astrazeneca through LinkedinField
